NO DECISIONDismissed95% confidenceGrok 4.3 (xAI)
Question
Will this trial show a positive result on Phase 3: Progression-Free Survival?
Found
Reviewed
Summary
No qualifying disclosure of exact Phase 3 PFS endpoint in randomized population; trial active/not recruiting, primary completion 2026-12-30, no results posted on CT.gov or sponsor sites.
Review Notes
Reviewed for the 2026-10-06 site refresh. The exact registry record was re-fetched and has no posted results. The monitor found no qualifying disclosure matching the locked endpoint. A YES or NO resolution is not supported; retain the open market and revisit when new evidence arrives. This closes the administrative review item without changing the market outcome.
Sources
ClinicalTrialsclinicaltrials.gov
Study Details | NCT05909397 | ClinicalTrials.gov
Active not recruiting; primary completion estimated 2026-12-30; no results posted for Phase 3 PFS.
Sponsorpfizeroncologydevelopment.com
Clinical Trial Details | Pfizer Oncology Development | NCT05909397
Active not-enrolling; lists Phase 3 PFS endpoint with timeframe to ~4 years; no data or results.